Garfield Alastair — SEC Form 4 filings
SEC reporting owner CIK 2027261. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-07-10 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 2 filings — 9,082 shares, $998,186 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 3,400 shares @ $118.28 ($402,167) in RHYTHM PHARMACEUTICALS, INC., filed 2026-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Chief Scientific Officer | 7 | — | 6 legs · 9,082 sh · $998,186 | 14 |
Form 4 filings — Garfield Alastair
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Sale (S): 2,007 @ $116.11 · Sale (S): 1,556 @ $117.08 · Sale (S): 3,400 @ $118.28 · Sale (S): 800 @ $119.17 | EDGAR |
| 2026-07-02 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,445 · Tax withholding (F): 2,150 @ $110.41 · Option exercise (M): 4,445 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 16,650 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 6,663 · Tax withholding (F): 2,026 @ $108.99 · Option exercise (M): 6,663 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,445 · Sale (S): 1,313 @ $64.81 · Sale (S): 6 @ $64.60 · Option exercise (M): 4,445 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 26,650 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-07-10 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 53,333 (derivative) @ $0 · Grant/award (A): 17,778 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2027261 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →